Navigation Links
FDLI's Food and Drug Policy Forum Examines European GMO Rules
Date:1/25/2011

WASHINGTON, Jan. 25, 2011 /PRNewswire-USNewswire/ -- The second issue of FDLI's Food and Drug Policy Forum (Volume 1, Number 2), to be published January 26, 2011, focuses on the increasingly important issue of genetically modified organisms (GMOs).

In the article published on the Food and Drug Law Institute's website (www.fdli.org), Ross H. Pifer, Director, and Richard J. Lupinsky, Jr., Research Fellow at the Agricultural Law Resource and Reference Center at Penn State University's Dickinson School of Law, make recommendations on this emerging international food and drug issue: "Should the European Union Proceed with the Implementation of New GMO Rules?"

Pifer and Lupinsky conclude that new GMO rules in the European Union need additional clarity to create a proper framework for the approval of genetically modified products, explaining that "stakeholders on all sides believe that the proposal actually will increase legal uncertainty and create more chaos surrounding both the decision-making process and labeling standards." The authors specifically recommend that the European Commission modify the major standard expressed in proposed Article 26b(a), a European Union Member States' Directive, to better explain the specific bases upon which Member States can restrict or prohibit cultivation of particular GMOs, integrate and harmonize the content of Article 26b with the Safeguard Clause, and maintain uniform standards of labeling for GMOs.

FDLI's Food and Drug Policy Forum is a twice-a-month, peer-reviewed, digital publication on current food and drug policy topics. Posed in the form of a question, each issue provides subscribers and purchasers with pertinent background information, relevant research, a discussion of central issues, relevant resources and policy recommendations. The views, opinions and statements expressed in the Policy Forum are those of the authors. The Food and Drug Law Institute neither contributes to nor endorses Policy Forum articles. As a nonprofit 501 (c) (3) organization, FDLI does not engage in advocacy activities.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI's scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

FDLI members receive the Policy Forum as a benefit of their membership. Non-members may subscribe to the Forum for a fee.


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Change in Medicare Wheelchair Policy May Prevent Texas Beneficiaries from Receiving Mobility Assistance Starting January
2. Rural Wheelchair Patients Will Be Hit Hard by Power Wheelchair Rental Policy; Providers, Advocates Ask Congress for a Delay
3. K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSEs Shareholder Approval Policy
4. Congress Urged to Delay New Medicare Wheelchair Rental Policy
5. Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs
6. Utahs Seniors and People with Disabilities Will Feel Impact of Medicare Policy Changes that Restrict Access to Power Wheelchairs
7. American College of Surgeons Health Policy Research Institute Releases Surgery Workforce Atlas That Shows Surgeon Shortage Across the U.S.
8. Physician Outraged by Medicare Power Wheelchair Documentation Policy
9. NORD Calls for Statement of Policy on Orphan Drug Development
10. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
11. Stryker Modifies Its Dividend Policy and Declares Transition Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... FREMONT, Calif. , July 13, 2017 RK ... (CA) Board of Pharmacy certification for its Fremont, ... chain support solutions in the Tri-Valley and San ... The City of Fremont , with its ... Logistics Group to provide such a powerful resource to the ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/10/2017)... -- US medical equipment and supply demand is forecast to ... Medical Equipment & Supplies: United States , a ... in demand for medical services – driven in large ... by gains in disposable personal income – will boost ... will also drive sales as providers and patients seek ...
Breaking Medicine Technology:
(Date:7/22/2017)... CANADA (PRWEB) , ... July 22, 2017 , ... ... offer patients with irreparable rotator cuff repairs the opportunity to return to sports ... the American Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Wettstein ... to communities in the greater Denver region, is announcing a charity drive to ... very rare kind of epilepsy. , Until a few months ago, Dominik was ...
(Date:7/21/2017)... Helena, AL (PRWEB) , ... July 21, 2017 ... ... that offers insurance assistance and financial planning services to communities in the greater ... that promises to provide resources to underprivileged young people in the region. , ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Theater of Witness , was awarded a $300,000 grant from The Pew Center ... empathy, comfort with ambiguity and the recognition of one’s own limits among health ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” ... plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it ...
Breaking Medicine News(10 mins):